C. Frederick LeMaistre
- Hematology top 5%
- Immunology top 10%
- Oncology
- Genetics top 10%
- Pathology and Forensic Medicine
- Co-authors
- Fiona E. CraigJames M. ReubenStephanie FarniaNavneet S. MajhailSergio GiraltStephen W. CrawfordPaul J. OrchardWael Saber
- Topics
- Hematopoietic Stem Cell Transplantation (11 papers)Toxin Mechanisms and Immunotoxins (4 papers)Acute Myeloid Leukemia Research (3 papers)
- Cited by
- HematologyImmunologyTransplantation
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
C. Frederick LeMaistre
21 papers receiving 688 citations
Peers
Comparison fields: 5 of 82
- Hematology 282
- Immunology 263
- Oncology 192
- Genetics 108
- Pathology and Forensic Medicine 105
Countries citing papers authored by C. Frederick LeMaistre
This map shows the geographic impact of C. Frederick LeMaistre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Frederick LeMaistre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Frederick LeMaistre more than expected).
Fields of papers citing papers by C. Frederick LeMaistre
This network shows the impact of papers produced by C. Frederick LeMaistre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Frederick LeMaistre. The network helps show where C. Frederick LeMaistre may publish in the future.
Co-authorship network of co-authors of C. Frederick LeMaistre
This figure shows the co-authorship network connecting the top 25 collaborators of C. Frederick LeMaistre. A scholar is included among the top collaborators of C. Frederick LeMaistre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Frederick LeMaistre. C. Frederick LeMaistre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 252 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 40 | |
| 8 | 11 | |
| 9 | 5 | |
| 10 | 6 | |
| 11 | Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. | 70 |
| 12 | 19 | |
| 13 | Isolation of primitive hematopoietic stem cells. | 17 |
| 14 | 28 | |
| 15 | 20 | |
| 16 | 7 | |
| 17 | 7 | |
| 18 | 12 | |
| 19 | Prevention of cyclosporine-induced nephrotoxicity with transdermal clonidine. | 5 |
| 20 | An immunotoxin cytotoxic for breast cancer cells in vitro. | 14 |
About C. Frederick LeMaistre
C. Frederick LeMaistre is a scholar working on Hematology, Transplantation and Biotechnology, having authored 21 papers that have together received 705 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Toxin Mechanisms and Immunotoxins (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (282 citations), Immunology (263 citations) and Transplantation (29 citations). C. Frederick LeMaistre has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Fiona E. Craig, James M. Reuben, Stephanie Farnia, Navneet S. Majhail, Sergio Giralt, Stephen W. Crawford, Paul J. Orchard, Wael Saber, David I. Marks and Richard E. Champlin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.